Jupiter Medical Center becomes the first in South Florida to employ the OPTRELL Mapping Catheter, a revolutionary tool that enhances the accuracy and efficacy of cardiac ablations for conditions like atrial fibrillation. Driven by the expertise of Dr. Matthew Kolek, the medical center is setting new standards in electrophysiology with advanced, minimally invasive treatments.
Read More
The FDA updates its guidance on paclitaxel-coated devices used in peripheral arterial disease treatment, stating no excess mortality risk is supported by updated trial data. This revision marks a significant milestone in ensuring patient safety and expanding treatment options.
Read MoreAccurKardia’s cloud-based AccurECG analysis system receives FDA clearance, allowing rapid and precise detection of 13 heart rhythms. This advancement in remote cardiac care brings specialist-level ECG interpretation to underserved communities and enhances workflow efficiency for clinical practitioners.
Read More
The BEST Trial, a randomized study comparing PCI with everolimus-eluting stents to CABG, provides valuable insights into the long-term cardiovascular outcomes in patients with multivessel CAD. While the initial results favored CABG, the BEST Extended Follow-Up Study demonstrates that advances in PCI procedures have narrowed the gap. However, the mortality benefit of CABG requires further investigation, emphasizing the importance of individualized patient discussions.
Read More
Dr. Steven Abramowitz at MedStar Washington Hospital Center has successfully performed the world’s first deep venous stent thrombectomies using an innovative minimally invasive catheter. The thrombectomy catheter, known as the “stent cleaner,” has shown exceptional procedural success rates, improving symptoms and offering a promising treatment option for patients with deep venous stent thrombosis.
Read More